ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
IQVIA and JDRF collaborate to improve understanding of Type 1 Diabetes using real world data
July 24, 2020The collaboration will pave the way for development of a real world research platform to facilitate evidence generation in type 1 diabetes for multiple stakeholders. -
Diasome Announces New Chairman of Scientific Advisory Board
December 16, 2019Diasome Pharmaceuticals named Dr. Jeremy Pettus the chairman of the company’s scientific advisory board. -
Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes
April 17, 2019Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes. -
AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes
March 07, 2019AnTolRx, Inc., a private biotechnology company and a leader in immune tolerance, today announced that Pfizer Inc has exercised the option granted under a June 2016 agreement to license an immune...
Pharma Sources Insight January 2025
